TG Therapeutics is a New York-based commercial-stage biopharmaceutical company that develops and markets novel therapies to treat cancer and autoimmune diseases.
Business Model:
Revenue: $5M
Employees: 201-500
Address: 2 Gansevoort Street
City: New York
State: NY
Zip: 10014
Country: US
TG Therapeutics is a New York-based commercial-stage biopharmaceutical company that develops and markets novel therapies to treat cancer and autoimmune diseases.
Contact Phone:
+18775758489
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/10/2003
Ticker Symbol:
TGTX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2012 | Post-IPO Equity | $25M | 1/2022 | Post-IPO Debt | $200M |
Hercules Capital, Inc. |
4/2010 | Private Placement | $3M | 2/2019 | Corporate Round | $85M | 12/2011 | Post-IPO Equity | $25M | 2/2009 | Private Placement | $1.7M | 12/2019 | Post-IPO Equity | $50M | 1/2022 | Post-IPO Debt | 1 | $70M |
Hercules Capital Hercules Capital Hercules Capital Hercules Capital |
2/2019 | Post-IPO Debt | 1 | $60M |
Hercules Capital Hercules Capital Hercules Capital Hercules Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|